Timepoint | T1 | T2 | T3 | T4 | T5 | T6 | T7 | T8 | T9 |
---|---|---|---|---|---|---|---|---|---|
Enrollment | X | X | Â | Â | Â | Â | Â | Â | Â |
Eligibility screen - EQ5D | X | X | Â | Â | Â | Â | Â | Â | Â |
Informed consent | X | X | Â | Â | Â | Â | Â | Â | Â |
Allocation | Â | X | Â | Â | Â | Â | Â | Â | Â |
Baseline questionnaires - HADS - MFIS - EQ5D - CAREQOL- MS | Â | Â | X | Â | Â | Â | Â | Â | Â |
3-month follow-up questionnaires - HADS - MFIS - EQ5D - CAREQOL- MS | Â | Â | Â | X | Â | Â | Â | Â | Â |
6-month follow-up questionnaires - HADS - MFIS - EQ5D - CAREQOL- MS - CSQ | Â | Â | Â | Â | X | Â | Â | Â | Â |
12-month follow-up questionnaires - HADS - MFIS - EQ5D - CAREQOL-MS | Â | Â | Â | Â | Â | X | Â | Â | Â |
Quality assurance | Â | Â | Â | Â | Â | Â | X | Â | Â |
Data analysis | Â | Â | Â | Â | Â | Â | Â | X | Â |
Results | Â | Â | Â | Â | Â | Â | Â | Â | X |